Federal officials on Sept. 9 sent 100 letters to companies telling them to cease misleading advertisements for pharmaceutical products, as President Donald Trump signed a new memorandum saying his administration would “ensure that the current regulatory framework for drug advertising results in fair, balanced, and complete information for American consumers.”
Trump said that officials with the Department of Health and Human Services and the Food and Drug Administration would take action to make sure that direct-to-consumer ads are transparent, accurate, and not misleading.
“Pharmaceutical ads hooked this country on prescription drugs,” Health Secretary Robert F. Kennedy Jr. said in a statement. “We will shut down that pipeline of deception and require drug companies to disclose all critical safety facts in their advertising. Only radical transparency will break the cycle of overmedicalization that drives America’s chronic disease epidemic.”…
Trump Signs Memo Targeting Direct-to-Consumer Pharmaceutical Advertising
